Hemorrhagic stroke in children occurs more frequently than is commonly appreciated. There are important differences in the factors associated with hemorrhagic stroke in children when compared with adults. These differences likely play a role in the different outcomes, which tend to worsen with age. In this review, we describe the estimated frequency, clinical presentation, acute management of hemorrhagic stroke, and an overview of rehabilitation techniques. We identify key topics for future basic and clinical research. Findings from future studies will help improve our ability to optimize treatment for and long-term rehabilitation of these patients.
MackayMTWiznitzerMBenedictSL. Arterial ischemic stroke risk factors: the International Pediatric Stroke Study. Ann Neurol. 2011;69:130–40.
4.
JordanLCRafayMFSmithSE. Antithrombotic treatment in neonatal cerebral sinovenous thrombosis: results of the International Pediatric Stroke Study. J Pediatr. 2010;156:704–710.
5.
GoldenbergNABernardTJFullertonHJ. Antithrombotic treatments, outcomes, and prognostic factors in acute childhood-onset arterial ischaemic stroke: a multicentre, observational, cohort study. Lancet Neurol. 2009;8:1120–1127.
6.
BeslowLALichtDJSmithSE. Predictors of outcome in childhood intracerebral hemorrhage: a prospective consecutive cohort study. Stroke. 2010;41:313–318.
LoWDLeeJRusinJ. Intracranial hemorrhage in children: an evolving spectrum. Arch Neurol. 2008;65:1629–1633.
9.
Al-JarallahAAl-RifaiMTRielaARRoachES. Nontraumatic brain hemorrhage in children: etiology and presentation. J Child Neurol. 2000;15:284–289.
10.
LivingstonJHBrownJK. Intracerebral haemorrhage after the neonatal period. Arch Dis Child. 1986;61:538–544.
11.
Meyer-HeimADBoltshauserE. Spontaneous intracranial haemorrhage in children: aetiology, presentation and outcome. Brain Dev. 2003;25:416–421.
12.
SchoenbergBSMellingerJFSchoenbergDG. Cerebrovascular disease in infants and children: a study of incidence, clinical features, and survival. Neurology. 1978;28:763–768.
13.
BroderickJTalbotGTPrengerE. Stroke in children within a major metropolitan area: the surprising importance of intracerebral hemorrhage. J Child Neurol. 1993;8:250–255.
14.
GiroudMLemesleMGouyonJB. Cerebrovascular disease in children under 16 years of age in the city of Dijon, France: a study of incidence and clinical features from 1985 to 1993. J Clin Epidemiol. 1995;48:1343–1348.
15.
FullertonHJWuYWZhaoSJohnstonSC. Risk of stroke in children: ethnic and gender disparities. Neurology. 2003;61:189–194.
16.
PerkinsEStephensJXiangHLoW. The cost of pediatric stroke acute care in the United States. Stroke. 2009;40:2820–2827.
17.
FullertonHJWuYWSidneySJohnstonSC. Recurrent hemorrhagic stroke in children: a population-based cohort study. Stroke. 2007;38:2658–2662.
18.
FullertonHJWuYWSidneySJohnstonSC. Risk of recurrent childhood arterial ischemic stroke in a population-based cohort: the importance of cerebrovascular imaging. Pediatrics. 2007;119:495–501.
19.
RothwellPMCoullAJGilesMF. Change in stroke incidence, mortality, case-fatality, severity, and risk factors in Oxfordshire, UK from 1981 to 2004 (Oxford Vascular Study). Lancet. 2004;363:1925–1933.
20.
QureshiAISuriMFNasarA. Changes in cost and outcome among US patients with stroke hospitalized in 1990 to 1991 and those hospitalized in 2000 to 2001. Stroke. 2007;38:2180–2184.
21.
FeiginVLLawesCMBennettDAAndersonCS. Stroke epidemiology: a review of population-based studies of incidence, prevalence, and case-fatality in the late 20th century. Lancet Neurol. 2003;2:43–53.
22.
YilmazCYucaSAYilmazN. Intracranial hemorrhage due to vitamin K deficiency in infants: a clinical study. Int J Neurosci. 2009;119:2250–2256.
23.
FeldmannEBroderickJPKernanWN. Major risk factors for intracerebral hemorrhage in the young are modifiable. Stroke. 2005;36:1881–1885.
24.
AriesenMJClausSPRinkelGJAlgraA. Risk factors for intracerebral hemorrhage in the general population: a systematic review. Stroke. 2003;34:2060–2065.
25.
QureshiAISuriMFYahiaAM. Risk factors for subarachnoid hemorrhage. Neurosurgery. 2001;49:607–612.
26.
TaylorCLYuanZSelmanWR. Cerebral arterial aneurysm formation and rupture in 20,767 elderly patients: hypertension and other risk factors. J Neurosurg. 1995;83:812–819.
27.
KernanWNViscoliCMBrassLM. Phenylpropanolamine and the risk of hemorrhagic stroke. N Engl J Med. 2000;343:1826–1832.
28.
NandaAVannemreddyPSPolinRSWillisBK. Intracranial aneurysms and cocaine abuse: analysis of prognostic indicators. Neurosurgery. 2000;46:1063–1067.
29.
MonaglePChalmersEChanA. Antithrombotic therapy in neonates and children: American College of Chest Physicians evidence-based clinical practice guidelines (8th edition). Chest. 2008;133(Suppl):887S–968S.
30.
Royal College of Physicians PSWG. Stroke in childhood: clinical guidelines for diagnosis, management and rehabilitation. http://www.rcplondon.ac.uk/pubs/books/childstroke2004Accessed January 15, 2011.
31.
RoachESGolombMRAdamsR. Management of stroke in infants and children: a scientific statement from a Special Writing Group of the American Heart Association Stroke Council and the Council on Cardiovascular Disease in the Young. Stroke. 2008;39:2644–2691.
32.
MorgensternLBHemphillJCIIIAndersonC. Guidelines for the management of spontaneous intracerebral hemorrhage: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2010;41:2108–2129.
33.
BedersonJBConnollyESJrBatjerHH. Guidelines for the management of aneurysmal subarachnoid hemorrhage: a statement for healthcare professionals from a special writing group of the Stroke Council, American Heart Association. Stroke. 2009;40:994–1025.
34.
HajatCHajatSSharmaP. Effects of poststroke pyrexia on stroke outcome: a meta-analysis of studies in patients. Stroke. 2000;31:410–414.
35.
ReithJJorgensenHSPedersenPM. Body temperature in acute stroke: relation to stroke severity, infarct size, mortality, and outcome. Lancet. 1996;347:422–425.
36.
FingasMPennerMSilasiGColbourneF. Treatment of intracerebral hemorrhage in rats with 12 h, 3 days and 6 days of selective brain hypothermia. Exp Neurol. 2009;219:156–162.
37.
FingasMClarkDLColbourneF. The effects of selective brain hypothermia on intracerebral hemorrhage in rats. Exp Neurol. 2007;208:277–284.
38.
MacLellanCLColbourneF. Mild to moderate hyperthermia does not worsen outcome after severe intracerebral hemorrhage in rats. J Cereb Blood Flow Metab. 2005;25:1020–1029.
39.
KollmarRStaykovDDorflerA. Hypothermia reduces perihemorrhagic edema after intracerebral hemorrhage. Stroke. 2010;41:1684–1689.
40.
SchwarzSHafnerKAschoffASchwabS. Incidence and prognostic significance of fever following intracerebral hemorrhage. Neurology. 2000;54:354–361.
41.
QureshiAIEzzeddineMANasarA. Prevalence of elevated blood pressure in 563,704 adult patients with stroke presenting to the ED in the United States. Am J Emerg Med. 2007;25:32–38.
42.
SchwarzSGeorgiadisDAschoffASchwabS. Effects of hypertonic (10%) saline in patients with raised intracranial pressure after stroke. Stroke. 2002;33:136–140.
43.
SchwarzSSchwabSBertramM. Effects of hypertonic saline hydroxyethyl starch solution and mannitol in patients with increased intracranial pressure after stroke. Stroke. 1998;29:1550–1555.
44.
BattisonCAndrewsPJGrahamCPettyT. Randomized, controlled trial on the effect of a 20% mannitol solution and a 7.5% saline/6% dextran solution on increased intracranial pressure after brain injury. Crit Care Med. 2005;33:196–202.
45.
HarutjunyanLHolzCRiegerA. Efficiency of 7.2% hypertonic saline hydroxyethyl starch 200/0.5 versus mannitol 15% in the treatment of increased intracranial pressure in neurosurgical patients—a randomized clinical trial [ISRCTN62699180]. Crit Care. 2005;9:R530–R540.
46.
HaysANLazaridisCNeyensRNicholasJGaySChalelaJA. Osmotherapy: use among neurointensivists. Neurocrit Care. 2011;14:222–228.
47.
MayerSABrunNCBegtrupK. Efficacy and safety of recombinant activated factor VII for acute intracerebral hemorrhage. N Engl J Med. 2008;358:2127–2137.
48.
DiringerMNSkolnickBEMayerSA. Thromboembolic events with recombinant activated factor VII in spontaneous intracerebral hemorrhage: results from the Factor Seven for Acute Hemorrhagic Stroke (FAST) trial. Stroke. 2010;41:48–53.
49.
ClaassenJJetteNChumF. Electrographic seizures and periodic discharges after intracerebral hemorrhage. Neurology. 2007;69:1356–1365.
50.
MesseSRSansingLHCucchiaraBL. Prophylactic antiepileptic drug use is associated with poor outcome following ICH. Neurocrit Care. 2009;11:38–44.
51.
YangTMLinWCChangWN. Predictors and outcome of seizures after spontaneous intracerebral hemorrhage. Clinical article. J Neurosurg. 2009;111:87–93.
52.
BladinCFAlexandrovAVBellavanceA. Seizures after stroke: a prospective multicenter study. Arch Neurol. 2000;57:1617–1622.
53.
VespaPMO’PhelanKShahM. Acute seizures after intracerebral hemorrhage: a factor in progressive midline shift and outcome. Neurology. 2003;60:1441–1446.
54.
MendelowADGregsonBAFernandesHM. Early surgery versus initial conservative treatment in patients with spontaneous supratentorial intracerebral haematomas in the International Surgical Trial in Intracerebral Haemorrhage (STICH): a randomised trial. Lancet. 2005;365:387–397.
55.
KirkmanMAMahattanakulWGregsonBAMendelowAD. The effect of the results of the STICH trial on the management of spontaneous supratentorial intracerebral haemorrhage in Newcastle. Br J Neurosurg. 2008;22:739–746.
56.
HofmeijerJKappelleLJAlgraA. Surgical decompression for space-occupying cerebral infarction (the Hemicraniectomy After Middle Cerebral Artery infarction with Life-threatening Edema Trial [HAMLET]): a multicentre, open, randomised trial. Lancet Neurol. 2009;8:326–333.
57.
JuttlerESchwabSSchmiedekP. Decompressive Surgery for the Treatment of Malignant Infarction of the Middle Cerebral Artery (DESTINY): a randomized, controlled trial. Stroke. 2007;38:2518–2525.
58.
VahediKHofmeijerJJuettlerE. Early decompressive surgery in malignant infarction of the middle cerebral artery: a pooled analysis of three randomised controlled trials. Lancet Neurol. 2007;6:215–222.
59.
RamaswamyVMehtaVBaumanM. Decompressive hemicraniectomy in children with severe ischemic stroke and life-threatening cerebral edema. J Child Neurol. 2008;23:889–894.
60.
SmithSEKirkhamFJdeVeberG. Outcome following decompressive craniectomy for malignant middle cerebral artery infarction in children. Dev Med Child Neurol. 2011;53:29–33.
61.
RangerASzymczakAFraserD. Bilateral decompressive craniectomy for refractory intracranial hypertension in a child with severe ITP-related intracerebral haemorrhage. Pediatr Neurosurg. 2009;45:390–395.
62.
BadjatiaNFernandezLSchmidtJM. Impact of induced normothermia on outcome after subarachnoid hemorrhage: a case-control study. Neurosurgery. 2010;66:696–700.
63.
FernandezASchmidtJMClaassenJ. Fever after subarachnoid hemorrhage: risk factors and impact on outcome. Neurology. 2007;68:1013–1019.
64.
DennisLJClaassenJHirschLJ. Nonconvulsive status epilepticus after subarachnoid hemorrhage. Neurosurgery. 2002;51:1136–1143.
65.
LinYJChangWNChangHW. Risk factors and outcome of seizures after spontaneous aneurysmal subarachnoid hemorrhage. Eur J Neurol. 2008;15:451–457.
66.
ClaassenJHirschLJFronteraJA. Prognostic significance of continuous EEG monitoring in patients with poor-grade subarachnoid hemorrhage. Neurocrit Care. 2006;4:103–112.
67.
RosengartAJHuoJDTolentinoJ. Outcome in patients with subarachnoid hemorrhage treated with antiepileptic drugs. J Neurosurg. 2007;107:253–260.
68.
FronteraJAClaassenJSchmidtJM. Prediction of symptomatic vasospasm after subarachnoid hemorrhage: the modified fisher scale. Neurosurgery. 2006;59:21–27.
69.
AllenGSAhnHSPreziosiTJ. Cerebral arterial spasm--a controlled trial of nimodipine in patients with subarachnoid hemorrhage. N Engl J Med. 1983;308:619–624.
70.
JordanLCJohnstonSCWuYW. The importance of cerebral aneurysms in childhood hemorrhagic stroke: a population-based study. Stroke. 2009;40:400–405.
71.
WojtachaMBazowskiPManderaM. Cerebral aneurysms in childhood. Childs Nerv Syst. 2001;17:37–41.
72.
HuangJMcGirtMJGailloudPTamargoRJ. Intracranial aneurysms in the pediatric population: case series and literature review. Surg Neurol. 2005;63:424–432.
73.
SanaiNQuinones-HinojosaAGuptaNM. Pediatric intracranial aneurysms: durability of treatment following microsurgical and endovascular management. J Neurosurg. 2006;104(Suppl):82–89.
74.
BeslowLStormPBLichtDJ. Hemorrhage volume is a predictor of short-term outcome in pediatric spontaneous intracerebral hemorrhage: a prospective consecutive cohort study. Stroke. 2009;40:e125.
75.
BlomIDe SchryverELKappelleLJ. Prognosis of haemorrhagic stroke in childhood: a long-term follow-up study. Dev Med Child Neurol. 2003;45:233–239.
76.
de RibaupierreSRillietBCottingJRegliL. A 10-year experience in paediatric spontaneous cerebral hemorrhage: which children with headache need more than a clinical examination?. Swiss Med Wkly. 2008;138:59–69.
77.
LanthierSCarmantLDavidM. Stroke in children: the coexistence of multiple risk factors predicts poor outcome. Neurology. 2000;54:371–378.
78.
LinCLLohJKKwanALHowngSL. Spontaneous intracerebral hemorrhage in children. Kaohsiung J Med Sci. 1999;15:146–151.
79.
LovelockCERinkelGJRothwellPM. Time trends in outcome of subarachnoid hemorrhage: population-based study and systematic review. Neurology. 2010;74:1494–1501.
80.
BiottiDJacquinABoutarbouchM. Trends in case-fatality rates in hospitalized nontraumatic subarachnoid hemorrhage: results of a population-based study in Dijon, France, from 1985 to 2006. Neurosurgery. 2010;66:1039–1043.
81.
van AschCJLuitseMJRinkelGJ. Incidence, case fatality, and functional outcome of intracerebral haemorrhage over time, according to age, sex, and ethnic origin: a systematic review and meta-analysis. Lancet Neurol. 2010;9:167–176.
82.
TaubEUswatteG. Constraint-induced movement therapy: bridging from the primate laboratory to the stroke rehabilitation laboratory. J Rehabil Med. 2003;(Suppl):34–40.
83.
WolfSLWinsteinCJMillerJP. Effect of constraint-induced movement therapy on upper extremity function 3 to 9 months after stroke: the EXCITE randomized clinical trial. JAMA. 2006;296:2095–2104.
84.
WolfSLThompsonPAWinsteinCJ. The EXCITE stroke trial: comparing early and delayed constraint-induced movement therapy. Stroke. 2010;41:2309–2315.
85.
WolfSLWinsteinCJMillerJP. Retention of upper limb function in stroke survivors who have received constraint-induced movement therapy: the EXCITE randomised trial. Lancet Neurol. 2008;7:33–40.
86.
NumataKMurayamaTTakasugiJOgaM. Effect of modified constraint-induced movement therapy on lower extremity hemiplegia due to a higher-motor area lesion. Brain Inj. 2008;22:898–904.
87.
MeinzerMElbertTDjundjaD. Extending the Constraint-Induced Movement Therapy (CIMT) approach to cognitive functions: Constraint-Induced Aphasia Therapy (CIAT) of chronic aphasia. Neurorehabilitation. 2007;22:311–318.
88.
TaubERameySLDeLucaSEcholsK. Efficacy of constraint-induced movement therapy for children with cerebral palsy with asymmetric motor impairment. Pediatrics. 2004;113:305–312.
89.
CopeSMLiuXCVerberMD. Upper limb function and brain reorganization after constraint-induced movement therapy in children with hemiplegia. Dev Neurorehabil. 2010;13:19–30.
90.
StearnsGEBurtnerPKeenanKM. Effects of constraint-induced movement therapy on hand skills and muscle recruitment of children with spastic hemiplegic cerebral palsy. Neurorehabilitation. 2009;24:95–108.
91.
CharlesJRGordonAM. A repeated course of constraint-induced movement therapy results in further improvement. Dev Med Child Neurol. 2007;49:770–773.
92.
TaubEGriffinANickJ. Pediatric CI therapy for stroke-induced hemiparesis in young children. Dev Neurorehabil. 2007;;10:3–18.
93.
GordonAConnellyANevilleB. Modified constraint-induced movement therapy after childhood stroke. Dev Med Child Neurol. 2007;49:23–27.
94.
GordonAMCharlesJWolfSL. Efficacy of constraint-induced movement therapy on involved upper-extremity use in children with hemiplegic cerebral palsy is not age-dependent. Pediatrics. 2006;117:e363–e373.
95.
HoareBJWasiakJImmsCCareyL. Constraint-induced movement therapy in the treatment of the upper limb in children with hemiplegic cerebral palsy. Cochrane Database Syst Rev. 2007;(2):CD004149.
96.
SakzewskiLZivianiJBoydR. Systematic review and meta-analysis of therapeutic management of upper-limb dysfunction in children with congenital hemiplegia. Pediatrics. 2009;123:e1111–e1122.
97.
FacchinPRosa-RizzottoMTurconiAC. Multisite trial on efficacy of constraint-induced movement therapy in children with hemiplegia: study design and methodology. Am J Phys Med Rehabil. 2009;88:216–230.
98.
BoydRSakzewskiLZivianiJ. INCITE: a randomised trial comparing constraint induced movement therapy and bimanual training in children with congenital hemiplegia. BMC Neurol. 2010;10:4.
99.
HoareBJImmsCRawickiHBCareyL. Modified constraint-induced movement therapy or bimanual occupational therapy following injection of botulinum toxin-A to improve bimanual performance in young children with hemiplegic cerebral palsy: a randomised controlled trial methods paper. BMC Neurol. 2010;10:58.
100.
CokerPLebkicherCHarrisLSnapeJ. The effects of constraint-induced movement therapy for a child less than one year of age. Neurorehabilitation. 2009;24:199–208.
101.
PsychouliPBurridgeJKennedyC. Forced use as a home-based intervention in children with congenital hemiplegic cerebral palsy: choosing the appropriate constraint. Disabil Rehabil Assist Technol. 2010;5:25–33.
102.
WallenMZivianiJHerbertR. Modified constraint-induced therapy for children with hemiplegic cerebral palsy: a feasibility study. Dev Neurorehabil. 2008;11:124–133.
103.
ParkESRhaDWLeeJD. The short-term effects of combined modified constraint-induced movement therapy and botulinum toxin injection for children with spastic hemiplegic cerebral palsy. Neuropediatrics. 2009;40:269–274.
104.
GilmoreRZivianiJSakzewskiL. A balancing act: children's experience of modified constraint-induced movement therapy. Dev Neurorehabil. 2010;13:88–94.
105.
WhelanAMDelgadoMR. Practice parameter: pharmacologic treatment of spasticity in children and adolescents with cerebral palsy (an evidence-based review): report of the quality standards subcommittee of the American Academy of Neurology and the Practice Committee of the Child Neurology Society. Neurology. 2010;75:669.
106.
WestmacottRAskalanRMacgregorD. Cognitive outcome following unilateral arterial ischaemic stroke in childhood: effects of age at stroke and lesion location. Dev Med Child Neurol. 2010;52:386–393.
107.
MaxJEManesFFRobertsonBA. Prefrontal and executive attention network lesions and the development of attention-deficit/hyperactivity symptomatology. J Am Acad Child Adolesc Psychiatry. 2005;44:443–450.
108.
MaxJERobinDATaylorHG. Attention function after childhood stroke. J Int Neuropsychol Soc. 2004;10:976–986.
109.
MaxJEMathewsKLansingAE. Psychiatric disorders after childhood stroke. J Am Acad Child Adolesc Psychiatry. 2002;41:555–562.
110.
MacLellanCLSilasiGPoonCC. Intracerebral hemorrhage models in rat: comparing collagenase to blood infusion. J Cereb Blood Flow Metab. 2008;28:516–525.
111.
WakhlooAKLieberBBSiekmannR. Acute and chronic swine rete arteriovenous malformation models: hemodynamics and vascular remodeling. AJNR Am J Neuroradiol. 2005;26:1702–1706.
112.
MarbacherSFandinoJKitchenND. Standard intracranial in vivo animal models of delayed cerebral vasospasm. Br J Neurosurg. 2010;24:415–434.
113.
ShiYLiZZhangS. Establishing a model of supratentorial hemorrhage in the piglet. Tohoku J Exp Med. 2010;220:33–40.
114.
LiuACSegarenNCoxTS. Is there a role for magnetic resonance imaging in the evaluation of non-traumatic intraparenchymal haemorrhage in children?. Pediatr Radiol. 2006;36:940–946.
115.
May-LlanasMEAlcover-BlochECambra-LasaosaFJ. [Non-traumatic cerebral hemorrhage in childhood: etiology, clinical manifestations and management]. An Esp Pediatr. 1999;51:257–261.
